Clinical Trial Update: Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating budesonide to prevent acute gastrointestinal graft-versus-host disease after allogeneic stem cell transplantation in leukemia patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Leukemia, Graft-Versus-Host Disease | Phase 3 | Status: COMPLETED